5LEDRO C D, TORRES D Y, LARIA L C, et al. Biochemical markers and bone densitometry in inflammatory bowel disease [J]. Rev Esp Enferm Dig,2000,92: 595-600. 被引量：1
6DOLAN A L, MONIZ C, DASGUPTA B, et al. Effects of inflammation and treatment on bone turnover and bone mass in polymyalgia rheumatica [J].Arthritis Rheum,2002,42: 2022-2029. 被引量：1
7PRINCE M, BANERJEE C, JAVED C, et al. Expression and regulation of Runx2/Cbfa1 and osteoblast phenotypic markers during the growth and differentiation of human osteoblasts[J].J Cell Biochem,2001, 80:424-440. 被引量：1
8WEINSTEIN R S, JILKA R L, PARFITT A M, et al. Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids: potential mechanisms of their deleterious effects on bone [J].J Clin Invest,2003,15: 274-282. 被引量：1
9PEARCE G, TABENSKY D A, DELMAS P D, et al. Corticosteroid-induced bone loss in men [J].J Clin Endocrinol Metab,2003,83:801-806. 被引量：1
10American College of Rheumatology ad hoc committee on glucocorticoid-induced osteoporosis. Recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis: 2001 update [J]. Arthritis Rheum,2001,44: 1496-1503. 被引量：1
